13.11
price down icon0.46%   -0.06
pre-market  Vorhandelsmarkt:  13.11  
loading
Schlusskurs vom Vortag:
$13.17
Offen:
$13.68
24-Stunden-Volumen:
920.13K
Relative Volume:
0.57
Marktkapitalisierung:
$1.63B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-115.88M
KGV:
-8.4756
EPS:
-1.5468
Netto-Cashflow:
$-104.72M
1W Leistung:
-7.55%
1M Leistung:
-8.19%
6M Leistung:
-50.90%
1J Leistung:
-27.21%
1-Tages-Spanne:
Value
$13.04
$13.84
1-Wochen-Bereich:
Value
$12.15
$14.85
52-Wochen-Spanne:
Value
$10.60
$38.12

Edgewise Therapeutics Inc Stock (EWTX) Company Profile

Name
Firmenname
Edgewise Therapeutics Inc
Name
Telefon
720-262-7002
Name
Adresse
1715 38TH ST, BOULDER
Name
Mitarbeiter
117
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-03
Name
Neueste SEC-Einreichungen
Name
EWTX's Discussions on Twitter

Vergleichen Sie EWTX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
EWTX
Edgewise Therapeutics Inc
13.11 1.63B 0 -115.88M -104.72M -1.5468
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.20 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
525.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
326.09 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
551.22 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
242.07 28.51B 3.81B -644.79M -669.77M -6.24

Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-30 Eingeleitet Guggenheim Buy
2025-04-02 Herabstufung Scotiabank Sector Outperform → Sector Perform
2025-03-07 Eingeleitet Scotiabank Sector Outperform
2025-01-22 Eingeleitet Stifel Hold
2024-11-22 Eingeleitet Evercore ISI Outperform
2024-03-07 Eingeleitet Piper Sandler Overweight
2023-05-01 Eingeleitet Truist Buy
2022-08-25 Herabstufung Goldman Neutral → Sell
2022-04-13 Eingeleitet RBC Capital Mkts Outperform
2022-01-28 Eingeleitet Goldman Neutral
Alle ansehen

Edgewise Therapeutics Inc Aktie (EWTX) Neueste Nachrichten

pulisher
Jun 18, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Shares Down 3.8%Here's What Happened - MarketBeat

Jun 18, 2025
pulisher
Jun 18, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Stake Boosted by GAMMA Investing LLC - MarketBeat

Jun 18, 2025
pulisher
Jun 17, 2025

Rhumbline Advisers Purchases 6,440 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World

Jun 17, 2025
pulisher
Jun 14, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $39.78 Average PT from Analysts - MarketBeat

Jun 14, 2025
pulisher
Jun 13, 2025

Enliven to sell $200M in stock after positive drug trial - BizWest

Jun 13, 2025
pulisher
Jun 10, 2025

Does Edgewise Therapeutics (EWTX) Have the Potential to Rally 174.68% as Wall Street Analysts Expect? - MSN

Jun 10, 2025
pulisher
Jun 10, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Transcript : Edgewise Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 03 - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

Bank of America Corp DE Has $1.31 Million Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Jun 09, 2025
pulisher
Jun 08, 2025

Edgewise Therapeutics (NASDAQ:EWTX) Receives "Outperform" Rating from Royal Bank of Canada - MarketBeat

Jun 08, 2025
pulisher
Jun 07, 2025

Ameriprise Financial Inc. Purchases Shares of 22,584 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Jun 07, 2025
pulisher
Jun 07, 2025

Royal Bank of Canada Reaffirms Outperform Rating for Edgewise Therapeutics (NASDAQ:EWTX) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Bank of America Corp DE Decreases Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Edgewise Therapeutics (EWTX) Receives Reaffirmed 'Outperform' Ra - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

RBC Capital maintains outperform rating on Edgewise Therapeutics stock By Investing.com - Investing.com India

Jun 05, 2025
pulisher
Jun 05, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Jun 05, 2025
pulisher
Jun 04, 2025

Universal Beteiligungs und Servicegesellschaft mbH Invests $2.40 Million in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Jun 04, 2025
pulisher
Jun 04, 2025

Edgewise Therapeutics to Present at the Annual Goldman Sachs Global Healthcare Conference - Eastern Progress

Jun 04, 2025
pulisher
Jun 03, 2025

Muscle Disease Leader Edgewise Therapeutics Set for Key Goldman Sachs Healthcare Conference Presentation - Stock Titan

Jun 03, 2025
pulisher
Jun 02, 2025

Two Sigma Investments LP Has $3.52 Million Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

Jun 02, 2025
pulisher
Jun 01, 2025

Certain Stock Options of Edgewise Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 2-JUN-2025. - marketscreener.com

Jun 01, 2025
pulisher
Jun 01, 2025

Certain Common Stock of Edgewise Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 2-JUN-2025. - marketscreener.com

Jun 01, 2025
pulisher
Jun 01, 2025

(EWTX) Technical Data - news.stocktradersdaily.com

Jun 01, 2025
pulisher
Jun 01, 2025

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Purchased by Nuveen Asset Management LLC - MarketBeat

Jun 01, 2025
pulisher
May 31, 2025

Polar Asset Management Partners Inc. Has $1.72 Million Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

May 31, 2025
pulisher
May 29, 2025

Edgewise Therapeutics: Upcoming DMD Trial Data May Disappoint (NASDAQ:EWTX) - Seeking Alpha

May 29, 2025
pulisher
May 28, 2025

Nuveen Asset Management LLC Acquires 158,452 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World

May 28, 2025
pulisher
May 27, 2025

Woodline Partners LP Has $15.15 Million Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

May 27, 2025
pulisher
May 27, 2025

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 174% Potential Upside in Biotech - DirectorsTalk Interviews

May 27, 2025
pulisher
May 27, 2025

BNP Paribas Financial Markets Makes New $883,000 Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

May 27, 2025
pulisher
May 26, 2025

106,562 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Purchased by Point72 Asset Management L.P. - MarketBeat

May 26, 2025
pulisher
May 25, 2025

Frazier Life Sciences Management L.P. Cuts Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

May 25, 2025
pulisher
May 24, 2025

Edgewise Therapeutics’ SWOT analysis: promising rare disease pipeline faces challenges By Investing.com - Investing.com South Africa

May 24, 2025
pulisher
May 24, 2025

Edgewise Therapeutics’ SWOT analysis: promising rare disease pipeline faces challenges - Investing.com India

May 24, 2025
pulisher
May 23, 2025

Polar Asset Management Partners Inc. Trims Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

May 23, 2025
pulisher
May 23, 2025

Tang Capital Management LLC Takes Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

May 23, 2025
pulisher
May 22, 2025

Deutsche Bank AG Grows Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat

May 22, 2025
pulisher
May 22, 2025

How to Take Advantage of moves in (EWTX) - news.stocktradersdaily.com

May 22, 2025

Finanzdaten der Edgewise Therapeutics Inc-Aktie (EWTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Edgewise Therapeutics Inc-Aktie (EWTX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Russell Alan J
Chief Scientific Officer
May 02 '25
Sale
16.45
1,551
25,520
18,521
MOORE JOHN R
General Counsel
May 01 '25
Option Exercise
0.00
5,209
0
8,461
MOORE JOHN R
General Counsel
May 02 '25
Sale
16.45
1,930
31,757
6,531
KOCH KEVIN
President and CEO
May 01 '25
Option Exercise
0.00
10,417
0
24,895
KOCH KEVIN
President and CEO
May 02 '25
Sale
16.45
4,276
70,358
20,619
Donovan Joanne M.
CMO
May 01 '25
Option Exercise
0.00
10,417
0
26,775
Donovan Joanne M.
CMO
May 02 '25
Sale
16.45
5,187
85,348
21,588
Derakhshan Behrad
Chief Business Officer
May 01 '25
Option Exercise
0.00
5,209
0
22,046
Derakhshan Behrad
Chief Business Officer
May 02 '25
Sale
16.45
1,691
27,824
20,355
Carruthers R Michael
Chief Financial Officer
May 01 '25
Option Exercise
0.00
5,209
0
82,328
$20.66
price up icon 0.78%
$36.03
price up icon 0.45%
$21.28
price up icon 3.30%
$100.64
price up icon 1.16%
$106.47
price down icon 0.23%
biotechnology ONC
$242.07
price up icon 0.36%
Kapitalisierung:     |  Volumen (24h):